Hjem › Ikke-småcellet lungekreft › Texas › League City
Kliniske studier for Ikke-småcellet lungekreft i League City, TX
15 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt League City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RekruttererFase 1
- The University of Texas, MD Anderson Cancer Center - League City, League City
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
RekruttererFase 3
- University Of Texas Medical Branch At Galveston, Galveston · 23 mi unna
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RekruttererFase 3
- The University of Texas, MD Anderson Cancer Center - League City, League City
- Texas Oncology - Gulf Coast, Webster · 3 mi unna
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruttererFase 3
- Kelsey-Seybold Clinic - Bay Area Campus Building A, Webster · 3 mi unna
- Kelsey-Seybold Clinic - Bay Area Campus Building B, Webster · 3 mi unna
- Kelsey-Seybold Clinic - Bay Area Campus Building C, Webster · 3 mi unna
- og 1 flere
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekruttererFase 2
- Texas Oncology-Gulf Coast, Webster · 3 mi unna
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
RekruttererFase 1
- Research Site, Galveston · 23 mi unna
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekruttererFase 2
- University of Texas Medical Branch, Galveston · 23 mi unna
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekruttererFase 3
- The University of Texas, MD Anderson Cancer Center - League City, League City
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
RekruttererFase 3
- Local Institution - 0692, Galveston · 23 mi unna
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
RekruttererFase 3
- Clinical Study Site, Webster · 3 mi unna
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- USO - Texas Oncology, Webster · 3 mi unna
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RekruttererFase 3
- Research Site, Webster · 3 mi unna
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekruttererFase 1
- Tranquil Clinical Research, Webster · 3 mi unna
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
RekruttererFase 2
- MD Anderson League City, League City
PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study
Rekrutterer
- University of Texas Medical Branch at Galveston, Galveston · 23 mi unna
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i League City
- Brystkreft12 studier
- Metastatisk kreft7 studier
- Ulcerøs kolitt6 studier
- Lungekreft6 studier
- Kolorektal kreft6 studier
- Kreft (alle typer)5 studier
- Eggstokkreft5 studier
- Slag5 studier
- Blærekreft4 studier
- Plateepitelcancer i hode og hals4 studier
- Prostatakreft4 studier
- Post-COVID-tilstander (lang-COVID)3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.